CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

IMCR Q2 Revenues Climb 18.3% as Kimmtrak Demand Helps Offset EPS Miss

EarningsKimmtrakPositive
AI Analysis

Summary

Immunocore reported Q2 revenues increased 18.3% driven by Kimmtrak demand, though the company missed on EPS expectations.

Financial Highlights

Revenue

18.3% increase

EPS

miss

Importance:5/10
Sentiment:
0.30
earningsrevenue growthproduct demandEPS miss
Related Companies

Read the original article

Published by yahoo_finance on August 10, 2026 3:39 PM

Read Original